WO2004045561A3 - Use of ferritin for immunomodulation - Google Patents

Use of ferritin for immunomodulation Download PDF

Info

Publication number
WO2004045561A3
WO2004045561A3 PCT/US2003/037593 US0337593W WO2004045561A3 WO 2004045561 A3 WO2004045561 A3 WO 2004045561A3 US 0337593 W US0337593 W US 0337593W WO 2004045561 A3 WO2004045561 A3 WO 2004045561A3
Authority
WO
WIPO (PCT)
Prior art keywords
ferritin
immunomodulation
maturation
differentiation
cell proliferation
Prior art date
Application number
PCT/US2003/037593
Other languages
French (fr)
Other versions
WO2004045561A2 (en
Inventor
Mario Stevenson
Simon Swingler
Original Assignee
Univ Massachusetts
Mario Stevenson
Simon Swingler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts, Mario Stevenson, Simon Swingler filed Critical Univ Massachusetts
Priority to AU2003293012A priority Critical patent/AU2003293012A1/en
Publication of WO2004045561A2 publication Critical patent/WO2004045561A2/en
Publication of WO2004045561A3 publication Critical patent/WO2004045561A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the discovery that ferritin is involved in the introduction of B cell proliferation, maturation, and differentiation. The invention includes compounds that modulate ferritin expression or activity. The invention also encompasses the use of ferritin to induce B cell proliferation, maturation, and differentiation.
PCT/US2003/037593 2002-11-20 2003-11-20 Use of ferritin for immunomodulation WO2004045561A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003293012A AU2003293012A1 (en) 2002-11-20 2003-11-20 Use of ferritin for immunomodulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42775402P 2002-11-20 2002-11-20
US60/427,754 2002-11-20

Publications (2)

Publication Number Publication Date
WO2004045561A2 WO2004045561A2 (en) 2004-06-03
WO2004045561A3 true WO2004045561A3 (en) 2004-07-15

Family

ID=32326589

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/037593 WO2004045561A2 (en) 2002-11-20 2003-11-20 Use of ferritin for immunomodulation

Country Status (2)

Country Link
AU (1) AU2003293012A1 (en)
WO (1) WO2004045561A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160271248A1 (en) * 2013-10-03 2016-09-22 Drexel University Cxcr4 up- and down-regulation for treatment of diseases or disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030021796A1 (en) * 2001-05-04 2003-01-30 Leszek Ignatowicz Method of enhancing T cell immunity by selection of antigen specific T cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030021796A1 (en) * 2001-05-04 2003-01-30 Leszek Ignatowicz Method of enhancing T cell immunity by selection of antigen specific T cells

Also Published As

Publication number Publication date
AU2003293012A8 (en) 2004-06-15
WO2004045561A2 (en) 2004-06-03
AU2003293012A1 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
WO2001083755A3 (en) Human anti-cd40 antibodies and methods of making and using same
AU4107300A (en) Polyurethane solutions containing alkoxysilane structural units
WO2003082208A3 (en) Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
AU2003286567A1 (en) Methods for the treatment of skin disorders
WO2004018058A3 (en) Compounds, compositions, and methods
WO2005107873A3 (en) Glycopyrrolate for treating childhood asthma
GB0111186D0 (en) Novel compounds
WO2004009036A3 (en) Compounds compositions and methods
AU2003219100A1 (en) Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3
PL374080A1 (en) Processes for the preparation of fibrinogen
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU2003255612A1 (en) Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
AU2003241915A1 (en) Vaporizer, various apparatuses including the same and method of vaporization
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
WO2004034972A3 (en) Compounds, compositions, and methods
WO2002076396A3 (en) Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
WO2004098522A3 (en) Gemini vitamin d3 compounds and methods of use thereof
WO2004045561A3 (en) Use of ferritin for immunomodulation
WO2004024086A3 (en) Compounds, compositions and methods
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2002365621A1 (en) Composition for treating the surface of the skin
AU2003289871A1 (en) 2-mercapto-substituted triazolopyrimidines, methods for the production thereof, the use of the same for controlling pathogenic fungi, and agents containing said compounds
AU2003269257A1 (en) Use of cap-1 for the therapy of asthma
AU2003238414A1 (en) Use of diuretics for treating swellings

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP